Condition
Male Osteoporosis
Total Trials
4
Recruiting
0
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
P 3 (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07518212Active Not RecruitingPrimary
OST and MORES in Male Osteoporosis
NCT03994172Phase 4Active Not RecruitingPrimary
Novel Combination Therapy for Osteoporosis in Men
NCT00439647Phase 3CompletedPrimary
Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis
NCT00397839Phase 3CompletedPrimary
The Effect Of Oral Ibandronate In Male Osteoporosis
Showing all 4 trials